Release 5 R6 Ballot (1st Draft)

This page is part of the FHIR Specification (v5.0.0: R5 - STU v6.0.0-ballot1: Release 6 Ballot (1st Draft) (see Ballot Notes ). This is the The current published version in it's permanent home (it will always be available at this URL). is 5.0.0 . For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3

Example MedicationDispense/meddisp0322 (Narrative)

Pharmacy Work Group Maturity Level : N/A Standards Status : Informative Compartments : Encounter , Patient , Practitioner

This is the narrative for the resource. See also the XML , JSON or Turtle format. This example conforms to the profile MedicationDispense .

Generated Narrative: MedicationDispense

Resource MedicationDispense "meddisp0322"

status : completed

Medications

- Concept
* Dilantin 125mg/5ml Oral Suspension Dilantin-125, 237 mL in 1 BOTTLE, GLASS (0071-2214-20) (package) ( National drug codes #0071-2214-20)

subject : Patient/pat1: Donald Duck "Donald DUCK"

Performers

- Actor
* Practitioner/f006 "Rob VAN DEN BERK"

authorizingPrescription : MedicationRequest/medrx0312

type : Refill - Part Fill ( ActCode #RFP)

quantity : 360 ml (Details: UCUM code ml = 'ml')

daysSupply : 30 Day (Details: UCUM code d = 'd')

whenPrepared : 2015-01-16T07:13:00+05:00

whenHandedOver : 2015-01-18T07:13:00+05:00

dosageInstruction

sequence : 1

text : 100mg (4ml) three times daily

timing : 3 per 1 days

route : Oral Route (qualifier value) ( SNOMED CT #26643006)

doseAndRate

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.